Rocksauce Fiery Hot Pain Relief

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the provision of soothing heat to alleviate discomfort associated with sore muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to apply the lotion liberally to the area of pain, ensuring thorough massage until the lotion is fully absorbed into the skin. This application should be repeated 3 to 4 times daily to achieve optimal therapeutic effects.

For storage, the lotion should be kept at a temperature range of 68° to 77°F (20° to 25°C) to maintain its efficacy.

Contraindications

Use of this product is contraindicated in the following situations:

• The product is not intended for use in children aged 5 years or younger.

• Administration should strictly adhere to the provided directions; any deviation is contraindicated.

• Heating, microwaving, or adding the product to hot water or any container that may cause splattering, leading to burns, is prohibited.

• Direct application to the eyes or mucus membranes is contraindicated.

• The product should not be ingested or placed in the nostrils.

• Application to wounds or damaged skin is not recommended.

Warnings and Precautions

The product is intended for external use only. It is imperative to avoid contact with the eyes, mucous membranes, or broken skin to prevent adverse reactions.

Users are advised to adhere strictly to the directions provided. The following precautions should be observed during use: the product must not be heated, microwaved, or added to hot water, as this may lead to splattering and potential burns. Additionally, it should not be applied to the eyes or directly on mucous membranes, ingested, or placed in the nostrils. Application to wounds or damaged skin is also contraindicated.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

If irritation occurs, it is essential to discontinue use and consult a healthcare professional. Pregnant or breastfeeding individuals should seek advice from a healthcare provider before using this product. Furthermore, individuals with sensitive skin are advised to consult a doctor prior to use to ensure safety.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes, mucous membranes, or broken skin. In clinical practice, it is important to consult a doctor and discontinue use if any irritation occurs.

Additionally, patients are advised to seek guidance from a health professional before using the product if they are pregnant or breastfeeding. Those with sensitive skin should also consult a doctor prior to use to ensure safety and minimize the risk of adverse reactions.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Rocksauce Fiery Hot Pain Relief (methyl salicylate, menthol, capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 5 years of age should not use this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage data, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, consultation with a poison control center may provide valuable guidance in the management of overdosage cases.

Continued vigilance and appropriate intervention are critical in ensuring patient safety in instances of potential overdosage.

Nonclinical Toxicology

No relevant information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no pertinent data concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center in the event of accidental ingestion. It is important to emphasize that this product is not intended for use in children aged 5 years or younger.

Patients should be instructed to use the product strictly as directed and to avoid any misuse. They should be cautioned against heating the product, microwaving it, or adding it to hot water, as these actions may lead to splattering and burns. Additionally, patients should be informed not to apply the product to the eyes, directly on mucous membranes, or to ingest it by mouth or place it in the nostrils. The product should not be applied to wounds or damaged skin.

Healthcare providers should recommend that patients consult a doctor and discontinue use if any irritation occurs. It is also advisable for patients to seek guidance from a health professional before using the product if they are pregnant or breastfeeding. Furthermore, patients with sensitive skin should be encouraged to consult a doctor prior to use.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 68° to 77°F (20° to 25°C) to maintain its efficacy and stability. Proper storage conditions should be observed to ensure the integrity of the product throughout its shelf life.

Additional Clinical Information

The product is administered topically, with patients advised to apply the lotion liberally to the area of pain and massage until fully absorbed into the skin. This application should be repeated 3-4 times daily.

Clinicians should counsel patients that the lotion is for external use only and must be kept away from the eyes, mucous membranes, and broken skin. Patients should be instructed to consult a doctor and discontinue use if irritation occurs. Additionally, it is recommended that individuals who are pregnant, breastfeeding, or have sensitive skin seek advice from a healthcare professional before use. The product should be kept out of reach of children, and in the event of accidental ingestion, medical assistance should be sought immediately. It is not intended for use in children aged 5 years or younger.

Drug Information (PDF)

This file contains official product information for Rocksauce Fiery Hot Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)